Technologies Designed to Improve Medical Diagnoses
and Patient Outcomes
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology, cardiology, neurology, and inherited diseases through advanced diagnostic technologies, products and services. Its ultra-sensitive ICE COLD-PCR™ powers the company’s liquid biopsy analyses that can be run on any sequencing platform to deliver a comprehensive genomic profile that includes all mutations. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies.